Hualan Biological Engineering
002007.SZ
#2950
Rank
A$6.76 B
Marketcap
$3.70
Share price
-0.23%
Change (1 day)
-25.53%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Revenue for Hualan Biological Engineering (002007.SZ)

Revenue in 2024 (TTM): A$1.02 Billion

According to Hualan Biological Engineering's latest financial reports the company's current revenue (TTM ) is A$1.05 Billion. In 2023 the company made a revenue of A$1.10 Billion an increase over the revenue in the year 2022 that were of A$0.97 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Hualan Biological Engineering from 2004 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) A$1.02 B-7.56%
2023 A$1.10 B13.1%
2022 A$0.97 B3.07%
2021 A$0.94 B-1.83%
2020 A$0.96 B26.98%
2019 A$0.76 B11.72%
2018 A$0.68 B49.97%
2017 A$0.45 B12.96%
2016 A$0.40 B25.48%
2015 A$0.32 B30.14%
2014 A$0.24 B20.23%
2013 A$0.20 B37.33%
2012 A$0.14 B2.01%
2011 A$0.14 B-21.01%
2010 A$0.18 B-7.14%
2009 A$0.19 B102.65%
2008 A$98.21 M83.98%
2007 A$53.38 M-5.67%
2006 A$56.58 M-6.43%
2005 A$60.47 M20.6%
2004 A$50.14 M